Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06724523 · ClinicalTrials.gov registry record
Pre- and Post- Descriptive Data of Language Outcomes in Deaf Children
A clinical trial of Sign Language Skills, sponsored by The University of Tennessee, Knoxville.
- Active
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT06724523: Active study of Sign Language Skills, sponsored by The University of Tennessee, Knoxville.
NCT06724523 is a study of Sign Language Skills that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06724523, a study of Sign Language Skills, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.
- ACTIVE NOT RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Deaf children between ages of 4-10 will provide pre and post data by responding to three prompts in sign language and written language at the beginning and end of a year. This data will provide information on the developmental trends and characteristics of deaf children who will receive SISI the following year.
Primary Outcome
Deaf children's sign language skills will be evaluated.
Conditions Studied
Interventions
- BEHAVIORAL Business-as-usual instruction
Study Locations (1)
Tennessee
- University of Tennessee, Knoxville - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-07-30 |
What the registry record for NCT06724523 still lists
NCT06724523 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Sign Language Skills appearing as the primary indexed condition, and to 1 intervention - of which Business-as-usual instruction is the first listed.
NCT06724523 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06724523 about?
NCT06724523 is a clinical study titled "Pre- and Post- Descriptive Data of Language Outcomes in Deaf Children". Deaf children between ages of 4-10 will provide pre and post data by responding to three prompts in sign language and written language at the beginning and end of a year. This data will provide information on the developmental trends and characteristics of deaf children who will receive SISI the fol...
What is the current status of trial NCT06724523?
This trial is currently active not recruiting. The enrollment target is 160 participants. The study started on 2024-08-01. Estimated completion is 2025-07-30.
What conditions does trial NCT06724523 study?
This clinical trial studies the following conditions: Sign Language Skills.
What interventions are being tested in trial NCT06724523?
The interventions under investigation include: Business-as-usual instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06724523?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06724523 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sign Language Skills
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI